Walgreens Recalls Pedi MVI Syringes Due to Sterility Concerns
Walgreens Infusion Services is recalling 73 syringes of Pedi MVI in Texas due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the risk of infection from non-sterile medical products.
Plain-English summary
Walgreens Infusion Services is recalling 73 syringes of Pedi MVI, a prescription-only medication compounded by Option Care 148 in San Antonio, Texas. The recall was initiated because of a lack of assurance of sterility in the product.
The affected product is distributed in Texas. The recall covers all lots within their expiry dates. No specific lot numbers or dates are provided in the source text.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions.
The recalled product
- Product
- Pedi MVI a) 5 mL, b) 10 mL syringe, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045
- Manufacturer
- Walgreens Infusion Services
- Category
- Drug — Compounded Medication
- Affected units
- 73
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 33 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 33 products in this recall →Related recalls
Same manufacturer · Walgreens Infusion Services
See all →- SevereWalgreens Recalls IVIG Gamunex Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls Cefazolin Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls 0.9% Sodium Chloride/MVI Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Infusion Services Recalls Dextrose and Sodium Chloride Injection Bags
FDA (Drugs) · 2016-01-06
- HighWalgreens Recalls Famotidine Injection Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
Same hazard · infection
See all →- SevereSafeguard US Operating LLC Recalls Compression Bandages Due to Degradation
FDA (Devices) · 2026-10-14
- SevereStryker Bard EP XT Decapolar Steerable Diagnostic EP Catheter Recalled for Sterile Barrier Breach
FDA (Devices) · 2026-10-14
- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- SevereAurolab Trust Recalls FOCUS PI Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-10-07
- HighFDA Recalls Performance Pro Nitrile Gloves Due to Defects
FDA (Devices) · 2026-10-07
Similar recalls
- SevereWalgreens Recalls Ranitidine Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-01-28
- SevereWalgreens Recalls Thiamine Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-01-28
- SevereWalgreens Recalls Folic Acid Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-01-28
- SevereGuardian Pharmacy Recalls Hyaluronidase Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereWalgreens Recalls Diphenhydramine Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-01-28
- SevereWalgreens Recalls L-cysteine Infusions Due to Sterility Concerns
FDA (Drugs) · 2015-01-28